Elizabeth Davis
Foot & Ankle Surgery · Hendersonville, NCNPI 1184049827
Payments from drug & device makers
What this record shows
36 manufacturers reported payments, led by Stryker at 26.5% of the total. Reporting peaked in 2019 at $4,895 and has fallen 65.4% since, to $1,694 in 2025.
Across 210 payments — averaging $61.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Integra Lifesciences Corporation$2K
- Treace Medical Concepts, Inc.$1K
- Paragon 28, Inc.$1K
- Organogenesis Inc.$1K
- Peerless Surgical Inc.$1K
- plus $3K from 30 others
What the payments were for
- Travel & lodging$5,26241%
- Food & beverage$7,69059%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 42 | $3,431 |
| Integra Lifesciences Corporation | 31 | $1,878 |
| Treace Medical Concepts, Inc. | 12 | $1,386 |
| Paragon 28, Inc. | 4 | $1,098 |
| Organogenesis Inc. | 35 | $1,087 |
| Peerless Surgical Inc. | 7 | $1,014 |
| DJO, LLC | 6 | $415 |
| Amgen | 10 | $278 |
| Johnson & Johnson | 6 | $253 |
| Arthrex | 4 | $206 |
| Abbott | 3 | $198 |
| Kerecis Limited | 3 | $178 |
| Paratek Pharmaceuticals, Inc. | 5 | $165 |
| In2bones USA, LLC | 1 | $149 |
| AbbVie | 2 | $146 |
| Inari Medical, Inc. | 1 | $145 |
| Smith+Nephew | 7 | $129 |
| Fusion Orthopedics USA, LLC | 1 | $108 |
| Vertex | 3 | $74 |
| KCI USA, Inc. | 2 | $69 |
| Boston Scientific | 1 | $56 |
| Melinta Therapeutics, LLC | 3 | $56 |
| Acell, Inc. | 3 | $52 |
| Zyla Life Sciences, Inc. | 2 | $42 |
| Orthofix Medical, Inc. | 2 | $40 |
| Axogen | 1 | $39 |
| Aroa Biosurgery Incorporated | 2 | $38 |
| Acera Surgical, Inc. | 2 | $37 |
| Dynasplint Systems Inc. | 1 | $32 |
| Nevro Corp. | 1 | $29 |
| Cardiovascular Systems Inc. | 1 | $27 |
| Zimmer Biomet | 2 | $24 |
| Viiv Healthcare Company | 1 | $22 |
| Convatec Inc. | 1 | $18 |
| Bioventus LLC | 1 | $15 |
| Mimedx Group, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$1,747
- Lapiplasty System$1,027
- Portfolio$988
- BILAYER WOUND MATRIX (BWM)$662
- INTEGRA WOUND MATRIX (IWM)$662
- IDRT$662
- FLOWABLE$662
- PRIMATRIX$661
- Kerecis SurgiClose$593
- INTEGRA$360
- VARIAX$347
- INTEGRA DERMAL REGENERATION TEMPLATE$262
- PuraPly$236
- CMF OL1000$229
- IBS$149
- NeoSpan$149
- CoLink$149
- CoLag$149
- Kerecis GraftGuide$148
- FLOWTRIEVER CATHETER, S$145
How this compares
$12,952 in reported general payments places this provider in the 85th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $5,982 |
| Gentamicin Sulfate | 30 | $1,006 |
| Ammonium Lactate | 43 | $793 |
| Gabapentin | 66 | $571 |
| Ciprofloxacin Hcl | 64 | $563 |
| Mupirocin | 89 | $516 |
| Doxycycline Hyclate | 41 | $456 |
| Cephalexin | 55 | $314 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 34 | $300 |
| Triamcinolone Acetonide | 19 | $182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $156 |
| Fluconazole | 16 | $155 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $124 |
| Clindamycin Hcl | 18 | $114 |
| Colchicine | 17 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $129 | $5,98216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 196 foot & ankle surgery providers in North Carolina.
Other foot & ankle surgery in Hendersonville
- Graham RigbyHendersonville$5K
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
- Kristen McGinnessFayetteville$123K
- William RespessGreenville$79K
- Brian FutrellCary$71K
- Kenneth BloomMooresville$53K
- Stephen HeislerChapel Hill$49K
- Benjamin UmbelMorganton$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.